BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17302207)

  • 1. A Korean family with an early-onset autosomal dominant macular dystrophy resembling North Carolina macular dystrophy.
    Kim SJ; Woo SJ; Yu HG
    Korean J Ophthalmol; 2006 Dec; 20(4):220-4. PubMed ID: 17302207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reappraisal of the clinical spectrum of North Carolina macular dystrophy.
    Khurana RN; Sun X; Pearson E; Yang Z; Harmon J; Goldberg MF; Zhang K
    Ophthalmology; 2009 Oct; 116(10):1976-83. PubMed ID: 19616854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign Yellow Dot Maculopathy: A New Macular Phenotype.
    Dev Borman A; Rachitskaya A; Suzani M; Sisk RA; Ahmed ZM; Holder GE; Cipriani V; Arno G; Webster AR; Hufnagel RB; Berrocal A; Moore AT
    Ophthalmology; 2017 Jul; 124(7):1004-1013. PubMed ID: 28366503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multimodal Imaging and Functional Testing in a North Carolina Macular Disease Family: Toxoplasmosis, Fovea Plana, and Torpedo Maculopathy Are Phenocopies.
    Small KW; Tran EM; Small L; Rao RC; Shaya F
    Ophthalmol Retina; 2019 Jul; 3(7):607-614. PubMed ID: 31043363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-familial occult macular dystrophy.
    Lyons JS
    Doc Ophthalmol; 2005 Jul; 111(1):49-56. PubMed ID: 16502307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dominant cystoid macular dystrophy.
    Saksens NT; van Huet RA; van Lith-Verhoeven JJ; den Hollander AI; Hoyng CB; Boon CJ
    Ophthalmology; 2015 Jan; 122(1):180-91. PubMed ID: 25267528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autosomal dominant Stargardt-like macular dystrophy segregating in a large Canadian family.
    Lagali PS; MacDonald IM; Griesinger IB; Chambers ML; Ayyagari R; Wong PW
    Can J Ophthalmol; 2000 Oct; 35(6):315-24. PubMed ID: 11091913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
    Boon CJ; van den Born LI; Visser L; Keunen JE; Bergen AA; Booij JC; Riemslag FC; Florijn RJ; van Schooneveld MJ
    Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autosomal dominant macular dystrophy simulating North Carolina macular dystrophy.
    Holz FG; Evans K; Gregory CY; Bhattacharya S; Bird AC
    Arch Ophthalmol; 1995 Feb; 113(2):178-84. PubMed ID: 7864750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of Stargardt's disease and fundus flavimaculatus.
    Armstrong JD; Meyer D; Xu S; Elfervig JL
    Ophthalmology; 1998 Mar; 105(3):448-57; discussion 457-8. PubMed ID: 9499775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new macular dystrophy with anomalous vascular development, pigment spots, cystic spaces, and neovascularization.
    Mahajan VB; Russell SR; Stone EM
    Arch Ophthalmol; 2009 Nov; 127(11):1449-57. PubMed ID: 19901210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late onset is common in best macular dystrophy associated with VMD2 gene mutations.
    Renner AB; Tillack H; Kraus H; Krämer F; Mohr N; Weber BH; Foerster MH; Kellner U
    Ophthalmology; 2005 Apr; 112(4):586-92. PubMed ID: 15808248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central areolar pigment epithelial dystrophy.
    Fetkenhour CL; Gurney N; Dobbie JG; Choromokos E
    Am J Ophthalmol; 1976 Jun; 81(6):745-53. PubMed ID: 937428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new dominant progressive foveal dystrophy.
    Frank HR; Landers MB; Williams RJ; Sidbury JB
    Am J Ophthalmol; 1974 Dec; 78(6):903-16. PubMed ID: 4440724
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical and genetic characterization of a Danish family with North Carolina macular dystrophy.
    Rosenberg T; Roos B; Johnsen T; Bech N; Scheetz TE; Larsen M; Stone EM; Fingert JH
    Mol Vis; 2010 Dec; 16():2659-68. PubMed ID: 21179233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of macular structure and function by OCT and electrophysiology in patients with vitelliform macular dystrophy due to mutations in BEST1.
    Schatz P; Bitner H; Sander B; Holfort S; Andreasson S; Larsen M; Sharon D
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4754-65. PubMed ID: 20375334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant occult macular dystrophy with an RP1L1 mutation (R45W).
    Hayashi T; Gekka T; Kozaki K; Ohkuma Y; Tanaka I; Yamada H; Tsuneoka H
    Optom Vis Sci; 2012 May; 89(5):684-91. PubMed ID: 22504327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An early-onset autosomal dominant macular dystrophy (MCDR3) resembling North Carolina macular dystrophy maps to chromosome 5.
    Michaelides M; Johnson S; Tekriwal AK; Holder GE; Bellmann C; Kinning E; Woodruff G; Trembath RC; Hunt DM; Moore AT
    Invest Ophthalmol Vis Sci; 2003 May; 44(5):2178-83. PubMed ID: 12714659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoinflammatory macular dystrophy.
    Dreyer RF; Hidayat AA
    Am J Ophthalmol; 1988 Aug; 106(2):154-61. PubMed ID: 3400757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Best vitelliform macular dystrophy in a Swedish family: genetic analysis and a seven-year follow-up of photodynamic treatment of a young boy with choroidal neovascularization.
    Frennesson CI; Wadelius C; Nilsson SE
    Acta Ophthalmol; 2014 May; 92(3):238-42. PubMed ID: 23617333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.